Publikationen: Prof. Dr. rer. nat. Volker Schirrmacher Archive - Seite 5 von 8 - IOZK

Beiträge

Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study

2008-11-08/in Breast Cancer, Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2008-11-08 / Cancer Immunol. Immunother. 2009 Jun;58(6):887-900

Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2

2008-10-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-10-01 / Int. J. Oncol. 2008 Oct;33(4):823-32

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

2008-06-05/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-06-05 / Virus Res. 2008 Sep;136(1-2):75-80

Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer

2008-06-03/in Colorectal Cancer, International Publications, IOZK Veröffentlichungen /von 2008-06-03 / Ann. Surg. Oncol. 2008 Aug;15(8):2310-7

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

2008-05-17/in Colorectal Cancer, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-9

An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins

2008-04-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-04-01 / Int. J. Oncol. 2008 Apr;32(4):777-89

Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007

2008-02-13/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-02-13 / Cancer Immunol. Immunother. 2008 Sep;57(9):1421-7

Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application

2007-11-01/in International Publications, Newcastle Disease Virus /von 2007-11-01 / Int. J. Oncol. 2007 Nov;31(5):1009-19

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy

2007-10-04/in International Publications, Newcastle Disease Virus /von 2007-10-04 / Gene Ther. 2007 Dec;14(23):1639-49

Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma

2007-07-24/in International Publications, Pancreatic Cancer /von 2007-07-24 / J. Natl. Cancer Inst. 2007 Aug;99(15):1188-99